caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1942212279

Michael HarrisM.D.

PRACTICECEDARS-SINAI MEDICAL FOUNDATIONSee all providers at this practice →
EndocrinologyBeverly Hills, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Michael Harris's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Stephen Deutsch
Internal Medicine · Beverly Hills, CA
29263
Unilab Corporation
Clinical Laboratory · West Hills, CA
26106
City Of Los Angeles
Ambulance Service Provider · Los Angeles, CA
2060
Elton Tourje
Diagnostic Radiology · Los Angeles, CA
1874
Raj Khandwalla
Cardiology · Beverly Hills, CA
1388
Alessandro Dagnolo
Diagnostic Radiology · Los Angeles, CA
1142
Jason Aaronson
Diagnostic Radiology · Los Angeles, CA
1144
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
886
Unique beneficiaries
—
Total services
1,406
Distinct HCPCS
12
Medicare payment
$81K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 633 Endocrinology providers in CA — above median (cohort median 1,164).
PRESCRIBING · PART D · 2024
Total Rx claims
5,861
Beneficiaries
—
Total drug cost
$1.4M
Distinct drugs
124
Brand share
34.3%
Top prescribed drugs
Levothyroxine Sodium559 claims
Atorvastatin Calcium254 claims
Levothyroxine Sodium234 claims
Amlodipine Besylate211 claims
Metformin Hcl205 claims
QUALITY · MIPS · 2024
Final MIPS score
89.1
Quality
84.8
Cost
73.2
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.60%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$137
Payment records
6
By payment type
Food and Beverage$102
Education$35